Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint)
JMIR Research Protocols · 2025
DOI: 10.2196/79865 ↗At a glance
Kohortenstudie in JMIR Research Protocols, 2025. Written by Swetambri Sharma and 14 co-authors. Institution: Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India. Major MEDLINE topics: Precursor Cell Lymphoblastic Leukemia-Lymphoma. 31 references. The full text is freely available in PubMed Central. Funded by: Swiss National Science Foundation.
Topics: Kinderkrankenpflege
Abstract (original language)
Není k dispozici žádný abstrakt.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Puducherry, 605006, India, 91 7675935408.
- Department of Pediatrics, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India.
- Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
- Department of Pharmacology, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India.
- Department of Pediatrics, Gynecology and Obstetrics, CANSEARCH Research Platform in Pediatric Oncology and Haematology, University of Geneva, Geneva, Switzerland.
ORCID profiles: Swetambri Sharma, Shuvadeep Ganguly, Kamali Murugadoss, Smita Kayal, Swaminathan Keerthivasagam, Archna Singh, Deepam Pushpam, Jayanthi Mathaiyan, Yvonne Gloor, Frederic Baleydier, Marc Ansari, Sameer Bakhshi, Biswajit Dubashi, Chakradhara Rao S Uppugunduri
Funding
- Swiss National Science Foundation
Cite
APA
Sharma, S., Ganguly, S., Murugadoss, K., Kayal, S., Keerthivasagam, S., Ramamoorthy, J., Singh, A., Pushpam, D., Mathaiyan, J., Gloor, Y., Baleydier, F., Ansari, M., Bakhshi, S., Dubashi, B., & Uppugunduri, C. R. S. (2025). Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint). JMIR Research Protocols. https://doi.org/10.2196/79865
Vancouver
Sharma S, Ganguly S, Murugadoss K, Kayal S, Keerthivasagam S, Ramamoorthy J, et al. Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint). JMIR Research Protocols. 2025. doi:10.2196/79865
BibTeX
@article{Sharma2025,
author = {Sharma, Swetambri and Ganguly, Shuvadeep and Murugadoss, Kamali and Kayal, Smita and Keerthivasagam, Swaminathan and Ramamoorthy, Jaikumar and Singh, Archna and Pushpam, Deepam and Mathaiyan, Jayanthi and Gloor, Yvonne and Baleydier, Frederic and Ansari, Marc and Bakhshi, Sameer and Dubashi, Biswajit and Uppugunduri, Chakradhara Rao S},
title = {Molecular and Pharmacogenetic marker evaluation in relation to the toxicity and clinical response of acute lymphoblastic leukemia treatment in Indian children (MPGx-INDALL) – A Prospective observational cohort study protocol (Preprint)},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/79865}
}
EUVIMED